About Biowave
Biowave is a company based in Norwalk (United States) founded in 2000.. Biowave has raised $2.08 million across 2 funding rounds. Biowave offers products and services including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps. Biowave operates in a competitive market with competitors including Saluda Medical, Nalu Medical, Myoscience, Neuros Medical and Alpha-Stim, among others.
- Headquarter Norwalk, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biowave Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.08 M (USD)
in 2 rounds
-
Latest Funding Round
$1.33 M (USD), Seed
Dec 06, 2019
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biowave
Biowave offers a comprehensive portfolio of products and services, including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable device for blocking severe pain in medical settings.
Non-surgical treatment providing up to 72 hours of pain relief.
Portable neurostimulation for personal chronic pain management.
Compact device offering up to 24 hours of fast pain relief.
Wearable compression for treating larger tissue areas with relief.
Unlock access to complete
Unlock access to complete
Funding Insights of Biowave
Biowave has successfully raised a total of $2.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.33 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.3M
-
First Round
First Round
(29 Jan 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Seed - Biowave | Valuation |
investors |
|
| Jan, 2016 | Amount | Seed - Biowave | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Biowave
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biowave
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biowave Comparisons
Competitors of Biowave
Biowave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Saluda Medical, Nalu Medical, Myoscience, Neuros Medical and Alpha-Stim, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
|
|
| domain | founded_year | HQ Location |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| domain | founded_year | HQ Location |
Technology-driven dermatological products are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| domain | founded_year | HQ Location |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biowave
Frequently Asked Questions about Biowave
When was Biowave founded?
Biowave was founded in 2000 and raised its 1st funding round 16 years after it was founded.
Where is Biowave located?
Biowave is headquartered in Norwalk, United States.
Is Biowave a funded company?
Biowave is a funded company, having raised a total of $2.08M across 2 funding rounds to date. The company's 1st funding round was a Seed of $749.43K, raised on Jan 29, 2016.
What does Biowave do?
Biowave Corporation develops and markets neuromodulation pain therapy devices aiming to aid physicians, physical therapists, and athletic trainers manage their patients or athletes pain and reduce the use of drugs. The BiowavePRO and Homewave neuromodulation devices deliver a therapeutic electrical pulse into deep tissue in the body blocking the transmission of pain. The devices have received marketing clearance from the FDA (Sep 2015) and are indicated to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, cervical spine, shoulder, elbow, wrist, hand, hip, knee, ankle and foot.
Who are the top competitors of Biowave?
Biowave's top competitors include Saluda Medical, Nalu Medical and Myoscience.
What products or services does Biowave offer?
Biowave offers BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps.